Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hammerschmidt

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
JAMA|January 15, 1982
Platelets and the environmentD E Hammerschmidt
Journal of the Mississippi State Medical Association|November 1, 1981
The stimulated granulocyte as an effector of immune injury or, the fickle phagocyte: friend or foe?D E Hammerschmidt
American Journal of Hematology|December 22, 1999
Disseminated histoplasmosis following prolonged low-dose methotrexate therapyV Roy, D E Hammerschmidt
American Journal of Clinical Pathology|September 1, 1980
Artifactual complement activation by blood-drawing apparatus. A clinical and investigational caveatD E Hammerschmidt, N Wilson
JAMA|May 22, 1981
Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lungH S Jacob, D E Hammerschmidt
The Journal of Laboratory and Clinical Medicine|June 1, 1994
Allegations of impropriety in manuscripts by Aws S. Salim: examination and withdrawal of journal aegis. The Executive Editorial Committee of the Journal of Laboratory and Clinical MedicineD E Hammerschmidt, A G Gross
Blood|October 1, 1986
Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulationK M Skubitz, D E Hammerschmidt
JAMA|July 3, 1981
The scientific mind at work (and play)H S Jacob, D E Hammerschmidt
International Anesthesiology Clinics|January 1, 1985
Immunological biocompatibility in blood substitutesG M Vercellotti, D E Hammerschmidt
Progress in Clinical and Biological Research|January 1, 1987
Granulocytes as mediators of tissue injury in shock: therapeutic implicationsD E Hammerschmidt, G M Vercellotti
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
JAMA|January 15, 1982
Platelets and the environmentD E Hammerschmidt
Journal of the Mississippi State Medical Association|November 1, 1981
The stimulated granulocyte as an effector of immune injury or, the fickle phagocyte: friend or foe?D E Hammerschmidt
American Journal of Hematology|December 22, 1999
Disseminated histoplasmosis following prolonged low-dose methotrexate therapyV Roy, D E Hammerschmidt
American Journal of Clinical Pathology|September 1, 1980
Artifactual complement activation by blood-drawing apparatus. A clinical and investigational caveatD E Hammerschmidt, N Wilson
JAMA|May 22, 1981
Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lungH S Jacob, D E Hammerschmidt
The Journal of Laboratory and Clinical Medicine|June 1, 1994
Allegations of impropriety in manuscripts by Aws S. Salim: examination and withdrawal of journal aegis. The Executive Editorial Committee of the Journal of Laboratory and Clinical MedicineD E Hammerschmidt, A G Gross
Blood|October 1, 1986
Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulationK M Skubitz, D E Hammerschmidt
JAMA|July 3, 1981
The scientific mind at work (and play)H S Jacob, D E Hammerschmidt
International Anesthesiology Clinics|January 1, 1985
Immunological biocompatibility in blood substitutesG M Vercellotti, D E Hammerschmidt
Progress in Clinical and Biological Research|January 1, 1987
Granulocytes as mediators of tissue injury in shock: therapeutic implicationsD E Hammerschmidt, G M Vercellotti
Pageof 12